Pfizer Inc.'s Lyrica pills are arranged for a photograph at New London Pharmacy in New York, U.S. Lyrica generated more than $800 million in sales in the first quarter for New York-based Pfizer. Photographer: JB Reed/Bloomberg
Pfizer Inc.'s Lyrica pills are arranged for a photograph at New London Pharmacy in New York, U.S. Lyrica generated more than $800 million in sales in the first quarter for New York-based Pfizer. Photographer: JB Reed/Bloomberg
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=311813343&utmp=%2Fphoto%2F2011-07-11%2Fpfizer-sues-apotex-over-generic-version-of-pain-drug-lyrica&utmhn=10.248.67.13&utmac=UA-11413116-12&utmhid=881168521)